Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and Survival
Insulin-like growth factor-binding protein (IGFBP)-2 regulates the bioactivity of the anabolic hormone’s insulin-like growth factors, which are decreased in sepsis and contribute to the catabolic status of severely ill patients. The circulating levels of IGFBP-2 in critical illness have been rarely...
Main Authors: | Patricia Mester, Ulrich Räth, Luisa Popp, Stephan Schmid, Martina Müller, Christa Buechler, Vlad Pavel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/12/3285 |
Similar Items
-
Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19
by: Patricia Mester, et al.
Published: (2023-07-01) -
Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity
by: Patricia Mester, et al.
Published: (2024-01-01) -
Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe Illness
by: Patricia Mester, et al.
Published: (2023-12-01) -
Reduced Plasma Bone Morphogenetic Protein 6 Levels in Sepsis and Septic Shock Patients
by: Niklas Schmidtner, et al.
Published: (2024-07-01) -
Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections
by: Pablo Amend, et al.
Published: (2023-06-01)